Amgen, Inc. (AMGN)
344.61
-1.12
(-0.32%)
USD |
NASDAQ |
Jun 09, 16:00
344.00
-0.61
(-0.18%)
After-Hours: 19:34
Amgen SG&A Expense (Quarterly) : 1.602B for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Biogen, Inc. | 607.30M |
| Gilead Sciences, Inc. | 1.451B |
| Regeneron Pharmaceuticals, Inc. | 647.70M |
| AbbVie, Inc. | 3.578B |
| Viridian Therapeutics, Inc. | 38.68M |